We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsor Data Must Support Need for Excess Drugs in Injectable Products
Sponsor Data Must Support Need for Excess Drugs in Injectable Products
The FDA is asking sponsors of ANDAs, BLAs and NDAs to justify the amount of excess medication they plan to pack in vials and ampules of injectable drug products.